The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study (NCT07342582) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study
United States670 participantsStarted 2026-05
Plain-language summary
The goal of this study is to determine the burden of Rhinoviruses (RVs) as a cause of acute, severe, respiratory illnesses leading to hospitalization. A community cohort of 120 children between 12 and 36 months of age will be enrolled in the first year of the study and followed (when well and sick) for 36 months to identify the circulating RVs and provide samples to establish a host nasal transcriptome differentiating clinical from subclinical RV infections. A hospitalized cohort of 450 infants and children will be enrolled during years 1 through 3 of the study and followed for the duration of their hospitalization to investigate the findings of the community cohort. An additional 100 healthy children aged 5-17 years will be enrolled for age-match comparison with the older hospitalized cohort.
Who can participate
Age range
17 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria (Aim 1 and Aim 2b Community Groups):
* Parent/legal guardian is willing and able to provide informed consent in English.
* Willing to comply with all study procedures and be available for the duration of the study.
* Younger Community Group: Generally healthy children 12 to 36 months of age at the time of enrollment
* Older Community Group: Generally healthy children 5 to 17 years of age at the time of enrollment.
* Current patient within primary care system at UW Health
Inclusion Criteria (Aim 2a: Hospitalized Group):
* Parent/legal guardian is willing and able to provide informed consent in English.
* Admitted to American Family Children's Hospital (AFCH) within the past 24 hours
* Children under 18 years of age at the time of enrollment
* Has a diagnosis of bronchiolitis, asthma exacerbation or CAP OR is an infant less than 6 months of age with fever greater than 38 degrees Celsius within 24 hours of hospital admission
Exclusion Criteria (all participants):
* Congenital or currently acquired immunosuppressive condition or medications (e.g., congenital immunodeficiency, Leukemia, Lupus)
* Congenital anomalies that might alter frequency of infection (e.g., unrepaired cleft palate, bronchial cyst, pulmonary sequestration)
* Presence of tracheostomy or gastrostomy tube
* Previously enrolled a different group in the study
* Other child in the same household already enrolled in the study
* Not suitable for study participation due to other reasons at the d…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Aim 1: Summary of Rhinovirus Types Identified in Community Cohort
Timeframe: data collected up to 36 months
2
Aim 1: Unique Nasal Transcriptomic Signature of Clinical Rhinovirus Infections